For instance, RUFY3, UNCX, PRSS33, and COL10A1 showed an increasing trend of absolute expression changes between the DCIS cases as a function of the number of times the DCIS samples were misclassified by the models. This evidence concerns the gene COL10A1 and ductal breast carcinoma in situ.